Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus.
暂无分享,去创建一个
D. Green | A. Maiorana | G. O'Driscoll | K. Stanton | R. Taylor | F. Colreavy | Daniel J. Green | Andrew Maiorana | Kim Stanton | Frances Colreavy | Roger Taylor
[1] C. Manso,et al. Angiotensin converting enzyme inhibitors as oxygen free radical scavengers. , 1993, Free radical research communications.
[2] S. Moncada,et al. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. , 1992, Journal of hypertension.
[3] G. Levine,et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.
[4] Farris K. Timimi,et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.
[5] A. Cerami,et al. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.
[6] D. Green,et al. The HMG-CoA reductase inhibitor, simvastatin, improves endothelial function within one month , 1997 .
[7] C. Cobelli,et al. Forearm Nitric Oxide Balance, Vascular Relaxation, and Glucose Metabolism in NIDDM Patients , 1997, Diabetes.
[8] P. Vanhoutte,et al. Endothelium-derived relaxing factors and converting enzyme inhibition. , 1995, The American journal of cardiology.
[9] D. Spiegelhalter,et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. , 1994, Journal of the American College of Cardiology.
[10] A. Chait,et al. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. , 1994, The Journal of clinical investigation.
[11] O. Carretero,et al. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. , 1992, Biochemical and biophysical research communications.
[12] B. Blanksby,et al. Lack of effect of vitamin E administration on basal nitric oxide function in male smokers and non-smokers. , 1995, Clinical science.
[13] G. Pieper. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. , 1997, Journal of cardiovascular pharmacology.
[14] H. Dargie,et al. The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro. , 1994, British journal of clinical pharmacology.
[15] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .
[16] D. Harrison,et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.
[17] D. Harrison,et al. Reversing endothelial dysfunction with ACE inhibitors. A new trend. , 1996, Circulation.
[18] D. Green,et al. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. , 1997, Circulation.
[19] R. Cohen,et al. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. , 1990, The Journal of clinical investigation.
[20] M. Creager,et al. -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw , 2016 .
[21] M. Kaufman. Comparison of the Free Radical‐scavenging Ability of Captopril and Ascorbic Acid in an In‐vitro Model of Lipid Oxidation. Implications for Reperfusion Injury and ACE Inhibitor Therapy , 1994, The Journal of pharmacy and pharmacology.
[22] H. Drexler,et al. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure. , 1995, The American journal of cardiology.
[23] J. Deanfield,et al. Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study. , 1998, Journal of the American College of Cardiology.
[24] H. Parving,et al. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy. , 1997, Scandinavian journal of clinical and laboratory investigation.
[25] P. Vallance,et al. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. , 1992, The Journal of clinical investigation.
[26] D. Celermajer,et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. , 1994, Journal of the American College of Cardiology.
[27] J. Hodgson,et al. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. , 1994, Journal of the American College of Cardiology.
[28] B. Blanksby,et al. Endothelium-derived nitric oxide activity in forearm vessels of tennis players. , 1996, Journal of applied physiology.
[29] F. Locatelli,et al. Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .
[30] J. Kastelein,et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. , 1997, The Journal of clinical investigation.
[31] A. Nitenberg,et al. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients. , 1996, Circulation.
[32] P. Vollenweider,et al. Nitric oxide release accounts for insulin's vascular effects in humans. , 1994, The Journal of clinical investigation.
[33] J. Deanfield,et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. , 1996, The New England journal of medicine.
[34] K. Emerk,et al. Protective effects of cilazapril against free radical injury in myocardial ischaemia-reperfusion. , 1995, Pharmacological research.
[35] P. Smits,et al. Effect of Long‐Term Angiotensin‐Converting Enzyme Inhibition on Endothelial Function in Patients with the Insulin‐Resistance Syndrome , 1995, Journal of cardiovascular pharmacology.
[36] J. McGill,et al. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. , 1995, The American journal of medicine.
[37] A. Takeshita,et al. Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme. , 1997, Journal of the American College of Cardiology.
[38] A. Nitenberg,et al. Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function , 1993, Diabetes.
[39] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[40] D. Webb,et al. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. , 1996, Circulation.
[41] Julie H. Campbell,et al. Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in culture. , 1994, Atherosclerosis.
[42] P. Groop,et al. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. , 1993, Clinical science.
[43] M. Quon,et al. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. , 1996, The Journal of clinical investigation.
[44] T. Lüscher,et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. , 1996, Circulation.
[45] N. Arakawa,et al. Endothelium-Dependent Vasodilation is Augmented by Angiotensin Converting Enzyme Inhibitors in Healthy Volunteers , 1992, Journal of cardiovascular pharmacology.
[46] A. Dart,et al. THERAPEUTIC RESTORATION OF ENDOTHELIAL FUNCTION IN HYPERCHOLESTEROLAEMIC SUBJECTS: EFFECT OF FISH OILS , 1994, Clinical and experimental pharmacology & physiology.
[47] N. Arakawa,et al. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure. , 1994, Journal of the American College of Cardiology.
[48] A. Baron,et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. , 1996, The Journal of clinical investigation.
[49] D. Celermajer,et al. Cigarette Smoking Is Associated With Dose‐Related and Potentially Reversible Impairment of Endothelium‐Dependent Dilation in Healthy Young Adults , 1993, Circulation.
[50] E. Ferrannini,et al. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. , 1995, Circulation.
[51] P. Cutler,et al. Tetrahydrobiopterin metabolism in the streptozotocin induced diabetic state in rats. , 1989, Clinica chimica acta; international journal of clinical chemistry.
[52] P. Brunetti,et al. Improved Insulin Action and Glycemic Control After Long Term Angiotensin-Converting Enzyme Inhibition in Subjects with Arterial Hypertension and Type II Diabetes , 1993, Diabetes Care.
[53] P Vallance,et al. Measuring forearm blood flow and interpreting the responses to drugs and mediators. , 1995, Hypertension.
[54] R. Cohen,et al. Vascular action of the hypoglycaemic agent gliclazide in diabetic rabbits , 1998, Diabetologia.
[55] L. Groop,et al. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. , 1994, JAMA.
[56] K. Tracey,et al. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.
[57] J. Ritter,et al. Vascular responsiveness and cation exchange in insulin-dependent diabetes. , 1991, Clinical science.
[58] S. Andreoli. Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury. , 1993, The American journal of physiology.
[59] E. Fleck,et al. Endothelium-mediated vasodilation during ACE inhibition. , 1995, European heart journal.
[60] P. Smits,et al. Endothelium-Dependent Vascular Relaxation in Patients With Type I Diabetes , 1993, Diabetes.
[61] D. Harrison,et al. Cellular and molecular mechanisms of endothelial cell dysfunction. , 1997, The Journal of clinical investigation.
[62] G. Watts,et al. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. , 1996, Clinical science.
[63] G. Watts,et al. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia , 1992, The Lancet.
[64] J. Baynes. Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.
[65] A. Takeshita,et al. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. , 1992, Hypertension.
[66] J. Deanfield,et al. Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. , 1998, Journal of the American College of Cardiology.
[67] F. Locatelli,et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. , 1996, The New England journal of medicine.
[68] D. Green,et al. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. , 1997, The Journal of clinical investigation.
[69] M. Creager,et al. Impaired Endothelium‐Dependent Vasodilation in Patients With Insulin‐Dependent Diabetes Mellitus , 1993, Circulation.